The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat (Psychopharmacology DOI: 10.1007/s00213-008-1319-0);The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat

Psychopharmacology

Volumn 201, Issue 4, 2009, Pages 529-539

  Kelsey, John E ^a   Langelier, Nicole A ^a   Oriel, Brad S ^a   Reedy, Catherine ^a  

^a BATES COLLEGE   (United States)

Author keywords

6 OHDA; Adenosine receptors; Caffeine; Dorsal striatum; Exterior globus pallidus; Parkinson's

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; CAFFEINE; LEVODOPA; OXIDOPAMINE;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; FOREFOOT; GLOBUS PALLIDUS; LOCOMOTION; LONG EVANS RAT; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; TREADMILL;

EID: 57049168269     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1361-y     Document Type: Erratum

References (51)

1. A Ascherio SM Zhang MA Hernán I Kawachi GA Colditz FE Speizer WC Willett 2001 Prospective study of caffeine consumption and risk of Parkinson's disease in men and women Ann Neurol 50 56 63
2. 2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease Exp Neurol 184 285 294
3. 2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation Psychopharmacology (Berl) 103 78 82
4. RJ Carey 1991 Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance Brain Res 568 205 214
5. O Cauli M Morelli 2005 Caffeine and the dopaminergic system Behav Pharmacol 16 63 77
6. 2 receptor agonists Behav Pharmacol 16 621 626
7. JW Chang SR Wachtel D Young UJ Kang 1999 Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions Neuroscience 88 617 628
8. M Correa A Wisniecki A Betz DR Dobson MF O'Neill MJ O'Neill JD Salamone 2004 The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism Behav Brain Res 148 47 54
9. TM Engber JJ Anderson RC Boldry SM Papa S Kuo TN Chase 1994 Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats Neuroscience 59 389 399
10. 2 receptors Eur J Neurosci 10 1878 1884
11. 2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats Eur J Pharmacol 321 143 147
12. 2 dopamine receptors in rat striatum Brain Res Mol Brain Res 14 186 195
13. BB Fredholm CG Persson 1982 Xanthine derivatives as adenosine receptor antagonists Eur J Pharmacol 81 673 676
14. K Fuxe U Ungerstedt 1974 Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists Med Biol 52 48 54
15. 2 heteromeric receptor complexes and their function J Mol Neurosci 26 209 220
16. 2A receptor antagonist in MPTP-treated monkeys Neurology 52 1673 1677
17. H Jiang V Jackson-Lewis U Muthane A Dollison M Ferreira A Espinosa B Parsons S Przedborski 1993 Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats Brain Res 613 347 351
18. 2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys Ann Neurol 43 507 513
19. 2A receptors modify motor function in MPTP-treated common marmosets NeuroReport 9 2857 2860
20. 2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys Exp Neurol 162 321 327
21. 2A antagonist SCH-58261 improve forepaw stepping in the unilateral 6-OHDA model of Parkinson's Disease. Society for Neuroscience Abstracts 31: Program No. 424.14
22. JE Kelsey SD Mague RS Pijanowski RC Harris NW Kleckner RT Matthews 2004 NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats Psychopharmacology (Berl) 175 179 188
23. 2A receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats Eur J Pharmacol 408 249 255
24. EL Lane SC Cheetham P Jenner 2006 Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease? Exp Neurol 197 284 290
25. PA Löschmann KW Lange M Kunow KJ Rettig P Jähnig T Honoré L Turski H Wachtel P Jenner CD Marsden 1991 Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease J Neural Transm Park Dis Dement Sect 3 203 213
26. 2a receptor antagonist KW-6002 in a rat model of L-DOPA-induced dyskinesia J Neurochem 84 1398 1410
27. M Lundblad B Picconi H Lindgren MA Cenci 2004 A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function Neurobiol Dis 16 110 123
28. J Maj A Rawlow J Sarnek 1976 The effect of theophylline and caffeine on neuroleptic-induced catalepsy Pol J Pharmacol Pharm 28 571 578
29. D Malec 1997 Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists Pol J Pharmacol 49 323 327
30. 2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model J Pharmacol Sci 103 329 332
31. 2A receptor antagonists: potential therapeutic and neuroprotective effects in Parkinson's disease Neurotox Res 3 545 556
32. M Olsson G Nikkhah C Bentlage A Bjorklund 1995 Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test J Neurosci 15 3863 3875
33. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, 5th edn. Academic, Burlington, MA
34. 1 agonists in dopamine-denervated rats Eur J Neurosci 8 1176 1181
35. 2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats Synapse 39 233 238
36. 2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease Synapse 61 606 614
37. 1 receptor stimulation in rodents Neurosci Lett 218 209 213
38. 2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets Eur J Pharmacol 546 82 87
39. S Rose N Ramsay Croft P Jenner 2007 The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of L-dopa in unilaterally 6-OHDA-lesioned rats Brain Res 1133 110 114
40. GW Ross RD Abbott H Petrovitch DM Morens A Grandinetti KH Tung CM Tanner KH Masaki PL Blanchette JD Curb JS Popper LR White 2000 Association of coffee and caffeine intake with the risk of Parkinson disease JAMA 283 2674 2679
41. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study J Neurochem 57 1062 1067
42. 2A receptors in Parkinson's disease Trends Neurosci 29 647 654
43. 2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP Psychopharmacology (Berl) 147 90 95
44. 2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions Exp Neurol 189 182 188
45. 2A receptor antagonists Exp Neurol 202 255 257
46. 2A receptor antagonist ST1535: acute and subchronic studies in rats Eur J Pharmacol 566 94 102
47. 2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats Pol J Pharmacol 55 155 164
48. 2A adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats Synapse 41 160 171
49. 2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice J Neurosci 26 13548 13555
50. 2A receptor antagonists in Parkinson's disease Pharmacol Ther 105 267 310
51. L Yu MA Schwarzschild JF Chen 2006 Cross-sensitization between caffeine- and L-dopa-induced behaviors in hemiparkinsonian mice Neurosci Lett 393 31 45